The risk for HCV reinfection among patients who reported injection drug use was increased in the initial period after curative treatment but decreased over time.
Monogram has obtained FDA clearance for mPress implants and applied for 510 (k) clearance for its robotic products. The Company is required to obtain FDA clearance before it can market its products.